Ledger.Open graph →
SEC Form D · filed April 15, 2015

Gemphire Therapeutics Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NORTHVILLE, MI
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

David Lowenschuss · Northville, MIExecMargaret Mcshane · Northville, MIExecKenneth Kousky · Midland, MIDirectorMina Sooch · Northville, MIExecAmy Zaremba Rabourn · Northville, MIDirectorCharles Bisgaier · Northville, MIExecP. K. Hawryluk · Carmel, INDirectorDaniela Oniciu · Gainesville, FLExecPaul Nasser · BOSTON, MADirectorKenneth Hood · San Diego, CAExecAmir Belson · Menlo Park, CAExecWilliam Alaynick · San Diego, CAExecDeborah L. Machovec · Wahoo, NEDirectorHurley Doddy · George Town, Grand Cayman, Cayman IslandsDirectorMarc A. Weiser · Ann Arbor, MIExecPravin V. Gandhi · Fort Mumbai, K7ExecBala V. Deshpande · Timonium, MDExecGeorge A. Parris · Audubon, IAExec · DirectorJon Cheek · SAN FRANCISCO, CAExec · DirectorScott D. Shallo · Kinderhook, NYDirectorDaniela Oniciu · Gainesville, FLExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗